If you are eligible to participate in a clinical trial, you may have access to new therapies that are not yet widely available. Clinical trials are research studies that evaluate the safety and effectiveness of new ways to diagnose and treat cancer. These studies can also help doctors compare the effectiveness of prevention strategies or other aspects of your care.
We are experienced in identifying people who are most likely to benefit from a particular therapy, and we can help guide you through the process of enrolling in the most appropriate clinical trial.
Researchers at Memorial Sloan Kettering are involved in developing and conducting studies with support from the National Cancer Institute’s AIDS Malignancy Consortium to evaluate new treatments for Kaposi sarcoma.
Here you can find a continually updated listing of Memorial Sloan Kettering’s current clinical trials for AIDS-associated cancers. To learn more about a study, choose from the list below.